Ximbio (www.ximbio.com) will change the way life science reagents are searched, sourced and shared. Through Ximbio researchers and technology transfer offices can virtually deposit their reagents to ...
Ximbio (www.ximbio.com) will change the way life science reagents are searched, sourced and shared. Through Ximbio researchers and technology transfer offices can virtually deposit their reagents to an online portal. Each reagent record can be linked to the originating inventor, enabling scientists and institutions to be credited for their work. Life science reagents companies can use Ximbio to easily source new products to augment their portfolios via a straightforward commercialisation process. Ximbio offers scientists looking for a specific reagent with a fully searchable database, extensive datasheets, peer reviews and supplier options. Ximbio is owned by Cancer Research Technology (CRT). A share of product-based revenues is returned to the depositing institution. Ximbio will focus on all areas of biology, and will broaden the range of tools available to scientists globally, to support and advance life science research.
Founded Year
2014
Organization Website
ximbio.com
Organization Languages
English
Current Technologies
rackspace mailgun
office 365
hubspot
cloudinary
cloudflare
google analytics
nginx
intercom
facebook widget
mobile friendly
youtube
linkedin widget
wistia
google tag manager
google plus login
new relic
linkedin login
facebook login
Job Functions
Sales
Product Management
Business Development
Marketing
hybridoma
cell lines
material transfer agreements
technology transfer
mouse models
licensing
biotechnology
Anjna Rising's Work History and Education
Ximbio
Business Development Manager
2014 - Present
NIHR Office for Clinical Research Infrastructure (NOCRI)